| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/28/2002 | CA2419872A1 Identification of a human n-terminal acetyltransferase gene |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2418730A1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2418134A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | CA2418104A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | CA2417787A1 Lipid metabolism enzymes |
| 02/28/2002 | CA2415852A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | CA2415846A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | CA2415791A1 Treatment of wounds |
| 02/28/2002 | CA2415788A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| 02/28/2002 | CA2411924A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting proteinkinases |
| 02/28/2002 | CA2388061A1 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | CA2356058A1 Intermittent administration of a growth hormone secretagogue |
| 02/27/2002 | EP1182194A1 Pernasal preparations |
| 02/27/2002 | EP1182192A1 4-hydroxypiperidine derivatives having antiarrhythmic effect |
| 02/27/2002 | EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders |
| 02/27/2002 | EP1181932A2 Therapeutic compositions comprising excess enantiomer of amlodipine |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181362A1 Methods and reagents for inhibiting angiogenesis |
| 02/27/2002 | EP1181354A1 Method for multiplying stem cells |
| 02/27/2002 | EP1181317A1 An integrin heterodimer and an alpha subunit thereof |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181305A1 Methods of modulating activity of prokaryotic ribosomes |
| 02/27/2002 | EP1181303A1 50 human secreted proteins |
| 02/27/2002 | EP1181302A1 Orally active a1 adenosine receptor agonists |
| 02/27/2002 | EP1181294A1 Novel derivatives and analogues of galanthamin |
| 02/27/2002 | EP1181286A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181285A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181282A2 Benzothiazinone and benzoxazinone compounds |
| 02/27/2002 | EP1181281A2 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists |
| 02/27/2002 | EP1181278A1 Cyclic amine derivatives and their uses |
| 02/27/2002 | EP1181270A2 Inhibitors of factor xa |
| 02/27/2002 | EP1181054A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
| 02/27/2002 | EP1181051A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF IMMUNOLOGICALLY-MEDIATED DISEASES USING i MYCOBACTERIUM VACCAE /i |
| 02/27/2002 | EP1181048A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| 02/27/2002 | EP1181026A2 Improved method for treating mammals with modified mammalian blood |
| 02/27/2002 | EP1181017A1 Metalloprotease inhibitors |
| 02/27/2002 | EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 02/27/2002 | EP1181010A1 Pharmaceutical chewing gum formulations |
| 02/27/2002 | EP0939623B1 Oral delayed immediate release formulation and method of preparation therefor |
| 02/27/2002 | EP0892789B1 Irreversible inhibitors of tyrosine kinases |
| 02/27/2002 | EP0825991B1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
| 02/27/2002 | EP0817770B1 Nonpeptides as tachykinin antagonists |
| 02/27/2002 | EP0792264B1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/27/2002 | EP0687251B1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 02/27/2002 | EP0651645B1 Medicament for inhibiting neutrophil elastase and cathepsin g |
| 02/27/2002 | CN1337966A Hesperitin pro-forms with enhanced bioavailability |
| 02/27/2002 | CN1337963A Pirazino (aza) indole derivatives |
| 02/27/2002 | CN1337961A Heteroaryl amidines, methyl amidiues and guanidines as protease inhibitors |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/27/2002 | CN1337884A Gene therapy for cardiomyopathy |
| 02/27/2002 | CN1337882A Pharmaceutical composition for the treatment o f rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 02/27/2002 | CN1337879A Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 02/27/2002 | CN1337877A Method of preparing stable suspension of insoluble microparticles |
| 02/27/2002 | CN1337403A Active monopeptide prepared from active blood polypeptide and its prepn. activity and sequence |
| 02/27/2002 | CN1337260A Prepn of piles eliminating medicine liquid |
| 02/27/2002 | CN1337259A Prepn of piles eliminating medicine liquid |
| 02/27/2002 | CN1337256A Application of compound Danshen drip pills in preparing medicine for primary hypertension |
| 02/27/2002 | CN1337247A Chinese medicine for treating piles |
| 02/27/2002 | CN1337246A Chinese medicine for treating cerebral thrombus sequelae |
| 02/27/2002 | CN1079791C Vitamin D. analogues |
| 02/27/2002 | CN1079642C Novel embolizing compositions |
| 02/26/2002 | US6350907 Matrix metalloprotease inhibitors |
| 02/26/2002 | US6350877 Manufacturing process |
| 02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
| 02/26/2002 | US6350856 Cytokine suppressive anti-inflammatory drug binding protein |
| 02/26/2002 | US6350778 Cardiovascular disorders |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350759 Dihydro- and tetrahydro-quinoline compounds |
| 02/26/2002 | US6350751 Therapeutic agents |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350745 Thrombin inhibitors |
| 02/26/2002 | US6350744 Pyrmidine or pyridine derivatives; antiarthritic and antiinflammatory agents; cachexia treatment; interleukin and tumor necrosis factor inhibitors |
| 02/26/2002 | US6350739 Methods of prevention and treatment of ischemic damage |
| 02/26/2002 | US6350735 Purine derivatives |
| 02/26/2002 | US6350729 Administering hemoglobin or myoglobin intravascularly as hypertensive agents |
| 02/26/2002 | US6350457 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 02/26/2002 | US6350446 Polypeptides with amino acid sequences for kidney failure |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/26/2002 | CA2057048C Vitamin d analogues |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/26/2002 | CA2024672C Indole, benzofuran,and benzothiophene containing lipoxygenase inhibiting compounds |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014487A2 Adeno-associated virus-mediated delivery of angiogenic factors |
| 02/21/2002 | WO2002014471A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014368A2 Proteins and nucleic acids encoding the same |